𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The risk of adverse cardiac events following minor surgery under discontinuation of all antiplatelet therapy in patients with prior drug-eluting stent implantation

✍ Scribed by Tanaka, Akihito; Sakakibara, Masaki; Ishii, Hideki; Okumura, Satoshi; Suzuki, Susumu; Inoue, Yosuke; Jinno, Yasushi; Okada, Koji; Murohara, Toyoaki


Book ID
122310689
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
162 KB
Volume
172
Category
Article
ISSN
0167-5273

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Discontinuation of antiplatelet therapy
✍ Daniel J. Brotman; Mihir Bakhru; Wael Saber; Ashish Aneja; Deepak L. Bhatt; Kath πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND Drug‐eluting coronary stents (DESs) pose a challenge in the perioperative period. Sirolimus and paclitaxel may inhibit reendothelialization of the traumatized vessel, making it vulnerable to platelet‐mediated thrombosis. Given the anecdotal evidence and case series sugges

Drug-Eluting Stenting Followed by Cilost
Drug-Eluting Stenting Followed by Cilost